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A SIMPLE INDEX OF SMOKING
Abhaya Indrayan Dr., Rajeev Kumar Mr., and Shridhar Dwivedi Dr.
Abstract
Background: Cigarette smoking is implicated in a large number of diseases and
other adverse health conditions. Among the dimensions of smoking are number of
cigarettes smoked per day, duration of smoking, passive smoking, smoking of fil-
ter cigarettes, age at start, and duration elapsed since quitting by ex-smokers. The
practice so far is to study most of these separately. We develop a simple index
that integrates these dimensions of smoking into a single metric, and suggest that
this index be developed further. Method: The index is developed under a series of
natural assumptions. Broadly, these are (i) the burden of smoking monotonically
increases with the cigarette-years but it is more severe in the beginning, (ii) start
of smoking early in life is more burdensome than a late start, and (iii) the bur-
den gradually reverses as the duration elapsed since cessation by ex-smokers in-
creases. Result: The index so arrived is: S = (3 – a/15)*1/2*sqrt[sumof(pi*ni*xi)
– 0.5] - y for S greater than equal to 0, and sumof(pi*ni*xi) greater than equal
to 0.5; otherwise zero (use a =30 for a>30); where i = 1, 2, . . . , I, and I is the
number of segments in life with different smoking pattern and a is the age at start
of smoking, pi is the proportion of smoke inhaled in case of passive smoking (or
adjustment for filter cigarettes or for other forms of smoking), xi is the number of
cigarettes smoked for ni years, and y is the number of years elapsed since cessation
by ex-smokers. Negative values of S are to be considered equal to zero. Examples
are given that demonstrate the use of this index. Conclusion: Just as almost any
other composite index, our index too could be good as a comprehensive measure
of burden of smoking but not to study its individual dimensions. This measures
the present burden in absolute sense and not the risk of smoking-related diseases.
Like body-mass index, the smoking index may have good correlation with the risk
of some diseases and poor for many others, depending upon the extent to which
the risk of disease agrees to our postulations.
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 A SIMPLE INDEX OF SMOKING  
Introduction 
Tobacco use is the top cause of disability-years in the world [1]. For the year 2015, WHO 
projected 6.4 million deaths attributable to tobacco consumption, which would be 10.0% of all deaths 
[2]. Thus the menace is increasing, and deserves greater attention.  
 Predominant use of tobacco is in terms of cigarette smoking. Other forms such as pipe, cigar 
and oral intake are perhaps not as common. Smoking of cigarettes is implicated in a large number of 
diseases and other adverse health conditions. These range from lung cancer to subfecundity [3-11].  For 
precise delineation of the role of smoking, it is important that smoking is assessed much more 
comprehensively than done so far. 
 One problem that has been consistently faced in studying smoking and its effects is the exact 
quantification of burden of smoking. Among various dimensions of smoking are number of cigarettes 
smoked per day, filter and nonfilter cigarettes, duration of smoking, duration elapsed since quitting by 
ex-smokers, age at start and passive smoking (environmental tobacco smoking). In some cases, features 
such as depth of inhalation, and time of first cigarette after wake up have also been studied [12]. 
Sometimes number and size of puffs and butt length are also considered [13].  So far, each of these 
dimensions is assessed separately for its effect, except for quantity and duration combined as pack-
years. Often some dimensions are ignored. Thus a holistic picture is not obtained. Given that it is such 
an important risk factor, smoking should be studied in more detail. It would be very convenient if an 
index is available that comprehensively measures different dimensions of smoking by a single metric. 
No index is available yet that can integrate different dimensions of smoking. 
 The objective of this communication is to present a simple index that can measure personal 
burden of smoking in a comprehensive manner. We propose to combine the current and past smoking 
Hosted by The Berkeley Electronic Press
  
2 
in terms of duration and cigarettes smoked, active and passive smoking, smoking of filter and regular 
cigarettes, duration elapsed since cessation by ex-smokers, and the age at start. Other features such as 
depth of inhalation and time of first cigarette after wake up are not included for two reasons. First, that 
would make the index too complex that could adversely affect its adoption. Second, these features are 
rarely studied probably because their effect is not considered substantial. In a study on risk of various 
types of lung cancer cells [12] indeed these features have been found of not much significance, 
although in a study on myocardial infarction, depth of inhalation was found significant [14].  
 We assume that the burden of passive smoking can be measured as a certain proportion of 
burden of active smoking. Further, we assume that the burden of smoking of filter cigarettes can be 
expressed as proportion of that of regular cigarettes. To develop the index, we also assume the 
following. All these are explained later. 
1. The dose of smoking can be measured in terms of cigarette-years.  
2. The burden monotonically increases strictly as the dose of smoking increases. There is no 
beneficial effect nor is there a state that smoking is harmless (unless it is as mild as stated in 
condition 2). See curve-1 and curve-2 respectively in Figure 1 that we exclude from the purview 
of our index. 
3. The burden of each additional cigarette-year of smoking is not as much as the previous cigarette-
year. The rate of increase in burden declines with dose of smoking though the burden itself 
continues to rise. This implies, for example, that first 5 years of smoking is more burdensome 
than the additional burden by smoking for 5 more years after, say, smoking for 10 years is already 
done. The admissible shape is designated as Working Hypothesis-I in Figure 1. See curve-3 that 
we keep outside the purview of our index.    
4. Start of smoking at early age causes more burden than a start late in life, and the relationship is 
linear (Figure 1). But after certain age, say 30 years, the age at start has the same influence as start 
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at age 30 years. This is our Working Hypothesis-II. We explain later that very few start smoking 
after the age of 30 years. 
5. The cumulative burden of smoking gradually reverses in a linear fashion as the duration elapsed 
since cessation increases (Figure 1). This is our Working Hypothesis-III. 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
Figure 1. The hypothesized trend of smoking index and some examples of trend excluded from  
                the purview of the index 
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These conditions are not all that restrictive as may seem. Some of these are conjectures and in the 
domain of epistemic uncertainties for which almost no data are available. We try to justify them as we 
proceed to develop the index. 
 It may be added as a word of caution that our index is not meant to measure the risk of any 
disease such as lung cancer. The index is an absolute quantity by itself that is intended to measure the 
current burden of cumulative smoking done by an individual. It may or may not relate well to the risk 
of smoking-related diseases. Thus this index has the same nature as body-mass index that relates well 
to the incidence of some diseases but not of so many other diseases.    
Development of the index 
 Cigarettes smoked per day is the natural measure of the magnitude of smoking. This is 
generally categorized as (1-9), (10-19), (20-29), etc., for the purpose of reporting of the results. Some 
investigators divide it arbitrarily into light and heavy. For example, Baird and Wilcox [13] considered 
20 or less cigarettes per day as light, and 21 or more heavy for studying fertility in women in the U.S.  
Petrauskaite et al. [15] used a cut-off of 7 cigarettes per day, and had categories 8-15 and 16+ also, 
although they did not call them as light, moderate and heavy. Their subjects were Lithuanian men 
residing near an industrial site, and the disease under investigation was lung cancer. Thus, variation 
exists in such categorization. As a side advantage, we hope to reduce, if not eliminate, such subjectivity 
by developing an index of smoking. 
 The next most commonly studied dimension of smoking is the duration of smoking. Ji et al. 
[16] divided it into (½-19), (20-29), (30-39) and (40+) years for the purpose of studying stomach 
carcinoma in China, whereas Hsing et al. [17] used 5-year categories beginning <25 years for prostate 
cancer in the U.S. veterans. Variation exists in this categorization also. 
 The cigarettes smoked per day and the duration of smoking are often combined into pack-years. 
The person-time is an epidemiologic tool that is commonly adopted when the duration of exposure 
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varies from person to person. This however assumes that  'dose' of smoking one cigarette per day for 10 
years is the same as the dose of 10 cigarettes per day for one year. This does not necessarily hold true 
for the hazard of smoking-related diseases. For example, it is known for lung cancer that duration is 
much more important than the number smoked per day [18].  But this assumption is implicit in all 
those studies that measure dose of smoking in terms of pack-years. MedLine search in Oct 2007 reveals 
728 citations that used the term pack-years for cigarettes. Despite its drawbacks, pack-year is just about 
the most commonly used measure of the dose of smoking. For example, this measure has been used by 
Uchimoto et al. [19] for Type-2 diabetes mellitus in Japan and by Hellenbrand et al. [20] for 
Parkinson’s disease in Germany. It is a simple and easy-to-comprehend measure. We use this as one of 
the important components in our proposed index also in a slightly modified form.  
 In our opinion, it is more convenient to measure cigarette-years than pack-years. First, history is 
predominantly taken in terms of cigarettes smoked per day rather than packs per day. Second, the size 
of pack may differ from country to country, time to time and brand to brand. There is a general 
agreement that a pack of cigarettes is defined to have 20 cigarettes but this can be overlooked by some 
researchers. Also, cigarette-years is not altogether in disuse. For example, Mao et al. [21] used this 
measure while reporting on unfavourable factors associated with low serum total cholesterol in 
Japanese population.  Cigarette-years obviate the need to round off, for example, 25 cigarettes a day to 
one pack. The other approximation often done in investigating smoking is in eliciting cigarettes 
smoked as life-time average over the duration of smoking (see, e.g., Siemiatycki et al. [22]). This could 
also be termed as ‘usual’ daily consumption as done by Stucker et al. [23]. If 10 cigarettes a day are 
smoked for three years and 20 a day for seven years, the respondent may report the average as 15 
though the actual average is 17. We therefore prefer to retain the exact number of cigarettes smoked 
per day, and use the duration for which specific number was smoked to calculate cigarette-years. This 
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defines our starting point for building up the index of smoking in this communication. Our initial 
measure of burden of smoking is the dose of smoking in terms of cigarette-years: 
    S1 =  ∑ ni xi , 
where xi  is the number of cigarettes smoked for ni years (i = 1, 2, …, I), and I is the number of 
segments in life with different smoking pattern. The number I may not be high for most smokers. If 
same number of cigarettes are smoked through out then I = 1. 
 The cigarette-years S1 is the cumulative dose for ‘active’ smokers. This can be adjusted for 
passive smokers. Passive smoking has been found to be a risk factor for lung cancer in Korea [24] and 
in India  [25]. Olsen [11] found it to be a risk factor for subfecundity in Danish women. Depending 
upon the extent of exposure to smoke, a proportion p can possibly be estimated that quantifies the 
smoker’s smoke inhaled by a person in the inhalation zone. This would be based on, for example, the 
cigarettes smoked by spouse when together, or similarly in workplace, and the duration of such 
exposure. The dose of smoking for a passive smoker is (pS1), where S1 now is the cigarette-years for 
which passive smoker is exposed. We could not locate any reference on the per cent inhaled by passive 
smokers but expect that the efforts will be made in future once our index catches attention. It has been 
estimated though that excess risk of lung cancer by passive smoking could be 15%  [26] whereas the 
OR in active heavy smokers can go upto 18.3   [27].  Matsubara et al. [28] reported 96 g less weight on 
average of infants born to active smoking mothers in Japan compared to non-smoker parents, and 11 g 
less weight of infants born to non-smoking mother but smoking father. In this case the effect of passive 
smoking is nearly 11% of that of active smoking. For stroke, Bonita et al. [29] observed for New 
Zealand residents that OR in those exposed to environmental tobacco smoke is 1.82, and in active 
smokers is 6.33. In this case, excess risk due to passive smoking is nearly 15% of the excess due to 
active smoking. In carotid atherosclerosis, mean intimal-medial wall thickness, adjusted for 
confounders, among middle-aged U.S. residents was found 0.738 mm in passive smokers relative to 
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0.807 mm in active smokers and 0.706 mm in never smokers [30]. Considering the thickness in never 
smokers as baseline, this increase amounts to an effect of nearly 32% in passive smoking relative to 
active smoking. As in the case of all other effects, the effect of passive smoking also varies from 
disease to disease, and from population to population. Nonetheless, in view of these evidences, we are 
proposing that passive smoking be provisionally considered as 15% of active smoking till such time 
that a firm evidence emerges. If 15% burden is assumed, the dose of passive exposure to 10 cigarettes a 
day for 8 years amounts to the dose of 12 cigarette-years of active smoking. For smoker himself or 
herself,  p = 1. The term we use for pS1  is ‘adjusted cigarette-years’. 
 The constant p can also be used as an adjustment for smoking filter cigarettes. Compared with 
regular cigarettes, filter cigarettes have been found to have reduced effect on lung cancer histology[31] 
although not on coronary heart disease [32]. Lee [33] has estimated that the risk of lung cancer by 
smoking filter cigarettes is about two-thirds of that of regular cigarettes. If three filter cigarettes are 
considered equivalent in toxicity to two nonfilter cigarettes then p = 0.67. In fact, if the history in 
sufficient detail is available, it is possible to incorporate separate components for passive smoking of 
regular cigarettes, passive smoking of filter cigarettes, active smoking of regular cigarettes and active 
smoking of filter cigarettes. In that case, (pS1) = (pa Sa) + (pb Sb) + (pc Sc) + (pd Sd), where the four 
components relate, respectively, to the four types of smoking. For active smoking of regular cigarette, 
pc = 1. Mathematically, it is more accurate to write it as∑ .iii xnp  
 Similar equivalence could be conjectured for cigars and pipes. For example, Hellenbrand et 
al.[20] considered 5 cigars and 2.5 pipes equivalent to a pack of 20 cigarettes each. One bidi, so 
common in India and other South Asian countries, is considered equal to one cigarette [34]. Any other 
equivalence can be considered. Perhaps similar equivalence can be established for smokeless tobacco 
also such as snuff, chew tobacco and betel quid. If so, the scope of our index would considerably 
enlarge. 
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 Small amount of smoking for a short duration is generally considered harmless. West et al. [9] 
used the limit of five packs over a life time to study the risk of nuclear cataracts in the U.S. fisherman. 
For the purpose of gastric ulcer in Australia, Mcintosh et al. [35] defined smoker as the one who 
smoked at least a cigarette a day for at least six months. We also consider the one who has smoked less 
than one-half of a cigarette-year in the whole life as good as a nonsmoker. Similarly, first one-half of a 
cigarette-year can be excluded for those who smoke more. Thus our first index is  
     ∑ iii xnp – 0.5, ∑ iii xnp ≥ 0.5, 
    S2 = 
0           otherwise. 
 
 The cumulative cigarette-years, as modified in S2, may range from zero to 1000 or higher. We 
postulated in Working Hypothesis-I that the cumulative burden of smoking is not linear but is severe in 
the beginning that tends to slow down as the dose increases. Field et al. [4] found no significant rise in 
odds ratio (OR) for breast cancer in the U.S. as the pack-years increased from one to more than 40. But 
Uchimoto et al. [19] found Type-2 diabetes mellitus related to pack-years in a dose dependent manner 
in a middle-aged Japanese population. Whether this relationship is linear or curvilinear is a moot 
question. Our review suggests that curvilinear relation is more commonly seen than the linear. For 
example, OR for stomach cancer in Chinese men [16] showed a rise from 1.05 for 10-19 pack-years to 
only 1.68 for 40+ pack years. In Japanese self-defense male officials [38] the OR for signoid colon 
carcinomas were 1.0, 2.1, 2.8 and 3.5 respectively for 0, 1-399, 400-499 and 500+ cigarette-years 
respectively. Thus it is not linear. Moderation generally applied for reduced rate of increase for 
advancing dose is the logarithm. But that would be too severe in this case as it would moderate 100 
cigarette-years to two and 1000 cigarette-years to only three. We searched for a simple function of S2 
that may take a value of nearly 5 for 100 cigarette-years and nearly 15 for 1000 cigarette years. The 
values 5 and 15 are our subjective assessment of the years that must elapse after quitting for the burden 
http://biostats.bepress.com/cobra/art40
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of such smoking to disappear in many cases. Further details are given later. The function given below 
has this feature.  
    S3 =  ½ 2S  
   
         =  ½ 5.0−∑ iii xnp , ∑ iii xnp ≥ 0.5. 
The minimum value of S3 is zero and the maximum for extremely heavy smokers can go upto 25 when 
50 cigarettes are smoked every day for 50 years! 
 Next, we incorporate an adjustment for the age at which smoking commenced. Hsing et al. 
[17] stated results for prostate cancer in the U.S. veterans beginning from less than 15 years for age at 
start of smoking and ending up with age 25 or more years. Ji et al. [16] started at less than 20 years of 
age and finished with 30+ in their results for studying stomach cancer in China. Although Vineis et al. 
[37] reported that the relative risk of bladder cancer in Italian subjects did not change with age at 
starting to smoke but there is otherwise overwhelming evidence that smoking exposure in early age is a 
risk factor. First, smoking in early age predicts longer duration of smoking, heavier daily consumption, 
increased nicotine dependence and less chances of quitting [38].  All these would be in our model any 
way. Age at start has relevance for our index only if it is an independent risk factor. Hirao et al. [39] 
observed increased prevalence of loss of heterozygosity on chromosome 3 at 3p21 with earlier age of 
smoking initiation among squamous cell carcinoma cases in the U.S. In former smokers in the U.S. 
Wiencke et al. [40] reported that age at smoking initiation was inversely associated with DNA adduct 
levels. A strong evidence comes from the study by Hegmann et al. [41] who found that men who began 
to smoke before age 20 had a substantially higher risk of developing lung cancer compared with those 
who started late, and this is after controlling for age, sex and amount of tobacco exposure. Larsson et 
al. [42] concluded for Swedish subjects that childhood exposure to environmental tobacco smoke is 
associated with an increased prevalence of asthma among adult never-smokers, especially in nonatopic 
subjects.  
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 We assume for the purpose of our index that the net burden of early start regresses with age if 
start is before the age 30 years, and remains at the same level thereafter. The figure in Giovino et al. 
[43] indicates that nearly all smokers in the U.S. start smoking by the age 30 years. The mean and SD 
provided by Lando et al. [44] for a population of working adults in the U.S. show, under Gaussian 
assumption, that less than 2% start smoking after the age of 27 years. Situation in other countries could 
be different but it seems safe to assume that very few start smoking after the age of 30 years. Passive 
smoking can start in childhood through parents, even as a fetus. We won’t be able to incorporate fetal 
smoking but arbitrarily assume that the burden of smoking, when started in infant period, is three times 
the burden when started at age 30 years or later, and the relationship is linear (Working Hypothesis–II). 
We explain this hypothesis in the next paragraph. This is the net effect of age at start on the burden of 
smoking independent of dose of smoking. This adjustment would mean that the start of smoking at age 
15 years is twice as much a burden as starting at age 30 years. This has special significance for passive 
smoking since that may indeed start in childhood  [45]. This assumption means, for example, that it 
would take 27 cigarette-years beginning at age 40 years to cause same burden as only 10 cigarette-years 
beginning at age 5 years. Though age also advances with duration but we assume that age per se 
remains an independent risk factor such as obesity is for coronary diseases and diet pattern is for some 
cancers.  
 Indeed not much evidence is available in support of our assumption regarding the exact 
magnitude of effect of early smoking postulated in Working Hypothesis–II. Hegmann et al. [41] 
reported nearly twice as much risk of developing lung cancer in the U.S. men when smoking started 
before the age of 20 years compared with those started at age 20 or older. Other diseases may have 
different pattern. We assume twice burden when age at start is 15 years relative to start at age 30 years 
or older. Absence of empirical evidence causes epistemic uncertainty that in our opinion can be filled 
up for the time being with some thing that otherwise looks rational. Working Hypothesis-II is an 
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expression of this approach. Future evidence may confirm or refute this assumption. In the case of the 
latter, the exact form of the index can be changed, although broad framework can still remain the same.  
With this, our index now becomes 
   (3 – a/15)S3    for a < 30 
  S4 =  
     S3    for a ≥ 30, 
 
where a is the age in years at start of smoking. 
 After accumulating all the negative aspects of smoking, our final adjustment is for the benefit 
of quitting smoking. While residual burden of smoking can remain for many years after cessation but it 
may decline as the duration elapsed increases. Stubbe et al. [46] reported increase in high density 
lipoprotein concentrations within six weeks of stopping by heavy smokers in Sweden. This may not be 
so dramatic for risk of diseases. Peto et al. [47] in a recent paper concluded that the former smokers had 
only a fraction of the lung cancer rate of continuing smokers, and this fraction fall steeply with time 
since stopping. In case of heart diseases, the risk reduces rapidly immediately after cessation and at a 
slower rate thereafter [48]. van Domburg et al. [49] estimated that benefit of survival for quitters in 
cases of coronary artery bypass surgery increased from 3% at five years to 14% at 15 years. The review 
of Critchley and Capewell [50] observed 36% reduction in risk of mortality in patients with coronary 
heart disease after quitting smoking although they were not able to assess how quickly does it happen. 
The mean length of follow-up in the studies reviewed by them was between 3 and 7 years. Speizer et 
al. [51] observed that the risk of lung cancer in middle-aged U.S. women rapidly decreased with 
discontinuation of smoking but took 15 years to fall to about the same level as risk for women who 
never smoked. Bueno de Mesquita [5] reported similar finding for exocrine pancreatic cancer. The 
pattern is different for different diseases. But these benefits partially explain why we earlier searched 
for a function that becomes zero if the duration elapsed is 15 years or more in case of heavy smoking 
and 5 years in case of moderate smoking. Our Working Hypothesis-III is that the burden would 
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gradually reverse linearly as the duration elapsed since quitting increases until it settles down to no 
burden. It would disappear after a very long time if the accumulated burden of smoking is heavy. With 
this adjustment, the index finally becomes 
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    S4 – y,   for  y < S4 
   S =  
    0,   for y ≥ S4, 
  
where y is the number of years elapsed since cessation. In terms of original data on smoking, this can 
be written as 
 (3 – a/15) ½ 5.0−∑ iii xnp   − y; (use a =30 for a ≥30), ∑ iii xnp ≥0.5, y < S4 
S =  
 0            otherwise 
 
where a   =  age in years at start of smoking,  
  
 
 Figure 2 Trend of smoking index on cigarettes per day or duration of smoking  (see text 
for notations) 
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Figure 3.  Trend of smoking index for different values of various smoking parameters (see text for 
notations) 
 
pi = proportion of smoke inhaled by passive smokers, or regular cigarette             equivalent to one 
filter cigarette when filter cigarettes are smoked (or similar equivalence for other 
forms of smoking), 
 xi =  number of cigarettes smoked (or exposure in case of passive smoking) for ni years, (i 
= 1, 2, …, I; where I is the number of segments with smoking of different numbers or 
type of cigarettes), 
and  y = years elapsed since stopped by ex-smokers. 
According to this index, if the smoking started at age 30 years and 400 cigarette-years are smoked then 
it would take nearly 10 years for the burden to vanish. But if the same smoking is done starting at age 
15 years, it would take nearly 20 years. Thus, this index gives large weight to smoking early in life, and 
is based on the assumption that the burden by smoking in childhood is much more than in the 
adulthood. Note that our restrictive conditions rule out the possibility of a negative value of the index. 
The minimum value is zero.  
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 Figures 2 illustrates the trend in this index with increasing duration of smoking or increasing 
cigarettes smoked per day. Both get the same weightage in line with the concept of pack-years. Trends 
of the index for different values of various parameters are shown in Figure 3. Note the trend of 
smoking index as the cigarette-years increase, and see how this declines for ex-smokers and increases 
for those who start smoking at early age. 
 
Computational example 
  Consider a male of age 46 years who quitted smoking 3 years ago following a coronary attack. 
He himself started smoking at the age of 18 years but was exposed to passive smoking throughout 
childhood. He estimates that his father was smoking nearly 6 cigarettes a day during the period when 
he and his father were together. He himself has smoked nearly 10 regular cigarettes a day for 3 years, 
15 filter-cigarettes a day for the next 7 years, and 6 cigars a day for the next 15 years.   
Assumptions -1. One filter cigarette = 2/3 regular cigarette 
            2. One cigar = 4 cigarettes 
           3. Passive smoking  = 15% of active smoking 
For active smoking ( pi = 1), ∑ ii xn = 10×3 + 2/3×15×7 + 4×6×15 = 460; 
For passive smoking till the age of 18 years, ∑ iii xnp = 0.15×6×18 = 16.2; 
Age at start, a = 18; 
Years since quitting, y = 3. 
Thus, smoking index for this person is 
  S  = (3 – 18/15) ½ 5.02.16460 −+   − 3 
      = 16.6. 
 
Discussion 
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 We have made a series of assumptions to keep the index simple. These can be changed as 
shown in the Appendix. In our opinion, any change in these assumption would be as arbitrary as the 
ones now proposed till such time that evidence in support or to the contrary emerges. The index 
actually is a metric of our assessment of the burden on any person at any point of time in life by 
smoking or exposure to smoking. But it is easy to call it an index of smoking. 
 The index suffers from the same demerits that almost all other composite indices do. It is likely 
to be good as a comprehensive metric for studying joint effect of different dimensions of smoking but 
is not appropriate if these dimensions are needed to be studied separately for etiologic reasons. For 
example, our index will not be very efficient in finding that start of smoking early in life is more of a 
burden or the large dose of smoking. Also, this index fails to segregate the effect of duration of 
smoking from the effect of the number of cigarettes. The effect of such individual dimensions of 
smoking in a multivariate setup can be studied although this is rarely done. Another problem with our 
index is its inability to take care of occasional smoking. While the volume of smoking can be 
calculated in terms of cigarette-years in this case also but the possible moderation in burden due to 
intermittent cessation [52] can not be studied by this index. Conventionally also this aspect is generally 
ignored. 
 The following advantages of the proposed index can be listed. These also are same as for 
almost any other index. 
1. It comprehensively measures several dimensions of smoking, and can be used to study the 
effect of smoking in an integrated manner. Thus there is no need to study ex-smokers separately 
from current smokers, and passive smokers separately from active smokers, unless needed for 
etiologic studies. It can also include smoking of bidis, pipes and cigars that quite often do not 
get attention. The index combines the qualitative and quantitative dimensions into a single 
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metric, and allows for a more direct comparison of the burden of smoking across various 
categories of tobacco use. 
2. The index can be used as a regular quantitative measure and it is not necessary to divide it into 
categories the way number of cigarettes and duration of smoking are almost invariably done. 
The subjectivity in categorization is entirely eliminated when the exact values of the index are 
used for analysis. When needed for a particular problem, categories such as mild, moderate and 
heavy burden of smoking can be formed by arbitrary divisions of the index values. We suggest 
5 and 10 as the cut-points. This subjectivity would be much less than the sum total of separate 
subjectivities presently occurring in categorizing the number of cigarette per day, duration of 
smoking, age at start, and time elapsed since quitting by ex-smokers.  
 No index can work equally well for all diseases. A simple index such as BMI = wt/ht2 
correlates well with risk of angina [53] but poorly with risk of lung cancer in older women [54]. Yet it 
is considered a valid measure of obesity. The index of activities of daily living [55]. is supposed to be a 
valid measure but it may not correlate well with, say, tumor stage in a patient. Our index is not disease 
specific just as is pack-years. It is extremely unlikely that any index of this nature would correlate well 
with all smoking related health conditions. It should give excellent correlation with the net risk (due to 
smoking) of a disease that fulfills the conditions stated earlier. In situations where not, and these are far 
more in number, the index will have less correlation despite smoking being a known risk factor. This 
does not diminish the utility of the index but only indicates that the disease is not affected by smoking 
the way we postulate as burden. The index may encourage generation of better data on different aspects 
of smoking that are sometimes ignored at present.  
 This index is not the last word on this topic but this is the most comprehensive attempt made so 
far. It contains most but not all the information contained in different dimensions of smoking. Using all 
the various dimensions of smoking simultaneously would always be superior, although this approach is 
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difficult to adopt. The index may have to be developed further once the assumptions are verified, and 
the difficulties in adopting the index are spelt out by the users.   
 The suggested proforma for eliciting smoking history required for this index is available with 
the first author (AI). This proforma is designed in easy-to-fill manner and to calculate the index for any 
present or past smoker. We realise that life long history of smoking may not be fully precise  there is 
always a chance of forgetting or of approximation. But that applies to some extent to pack-years also, 
which is now in common use. We expect that the history would be reasonably accurate to give fairly 
precise value of the index. Given the importance of smoking in many diseases, it may be worthwhile to 
spend extra time and effort to elicit accurate and complete history. Once this is available, the index can 
be easily calculated. The index has side advantages in terms of its potential to encourage further work. 
For example, the investigators would be encouraged to find how many filter cigarettes are required to 
produced same burden as 100 nonfilter (regular) cigarettes;  what percentage of smoke is inhaled in 
case of passive smoking; how early start of smoking affects the course of the disease, etc. Once these 
questions are precisely answered the index can be accordingly modified. 
 
Validation example 
 Our Department of Medicine runs a Preventive Cardiology Clinic twice a week in the 
afternoon. Besides present and past known cases of coronary artery diseases (CAD), many subjects 
who apprehend or anticipate heart problem of any type come to this clinic for advice. The subjects 
reporting in this clinic are routinely assessed for different risk factors such as obesity, smoking, alcohol 
intake and diet. A patient with stable or unstable angina, or with present or past history of myocardial 
infarction is labeled as a case of CAD. 
 Although smoking history has always been part of the assessment but after development of this 
index, smoking history is taken on a more elaborate format so that all aspects as required to compute 
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the index could be covered. This exercise started in March 2007 and is still going on. The data we now 
use to illustrate the smoking index belongs to all the new consecutive subjects that visited this clinic 
from March 2007 to October 2007. A total of 254 subjects visited the clinic during this 8-month 
period. Smoking history was incomplete in 2 cases. Thus the present analysis is based on the 
information on 252 subjects. The age of the subjects ranges from 21 years to 90 years with heavy 
concentration in forties and fifties (40.1%). The percentage of females is 24.2. Nearly 16% were bidi 
smokers. This is roll of a plant leaf with tobacco inside and is a low-cost local variant of cigarette. 
Distribution of subjects by different smoking parameters is given in Table 1. Univariate odds ratios 
(ORs) are also mentioned in this table. These clearly indicate that odds of CAD increase with smoking 
and its different dimensions among attendees of this clinic. 
Table 1.  Smoking history of subjects without and with CAD among preventive cardiology clinic 
attendees   
 
Number of subjects  
Particulars Without CAD With CAD 
Univariate OR 
(ref: Never smoker) 
Total 
 
Smoking status 
            Never smoker 
            Current smoker 
            Past smoker 
 
      140 (100.0) 
  
 
        85 (59.9) 
      45 (31.7) 
10 (  7.0) 
       
        112(100.0) 
 
 
   31 (27.7) 
   71 (63.3) 
         10 (  8.9) 
 
    
 
    1.00 
    4.33 
    2.74       
Ever smokers (n=136) 
Age at start (yrs) 
<20 years 
20-30 years 
 30+ years 
55 (38.7) 
 
 5  (3.5) 
26 (18.3) 
24 (16.9) 
 81(72.3) 
 
 17 (15.2) 
 44 (39.3) 
 20 (17.9) 
 
4.04 
 
9.32 
4.64 
 2.28 
Type of smoking 
Cigarette-filter 
Cigarette-nonfilter 
Bidi 
 
6   (4.2) 
 37 (26.1) 
12   (8.5) 
 
6  (5.4) 
46 (41.1) 
29 (25.9) 
 
2.74 
3.41 
                6.63 
Cigarettes per day (average) 
  <10 
  10-20 
  ≥20 
 
              10  (7.0) 
19 (13.4) 
26 (18.3) 
 
15 (13.4) 
35 (31.3) 
31 (27.7) 
 
4.11 
5.05 
3.27 
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Duration of smoking (years) 
<10 
10-20 
≥20 
 
  24 (16.9) 
              17 (12.0) 
             14  (9.9) 
 
      4   (3.6) 
30 (26.8) 
47 (42.0) 
 
0.46 
4.84 
                9.21 
Years since stopped 
0 (current smoker) 
        <5 
≥5 
 
 
              45 (31.7) 
5   (3.5) 
5   (3.5) 
 
 
71 (63.4) 
8  ( 7.1) 
2   (1.8) 
 
 
4.33 
4.39 
1.10 
 
In parentheses are percentage  
 
 Among many that could have been tried, we present results for three types of logistic model. 
These are labeled as Logistic-1, Logistic-2 and Logistic-3 in Table 2. The first is the conventional setup 
with age, duration-of-smoking, cigarettes-per-day, age-at-start and type-of -smoking (never smoker, 
filter cigarette, nonfilter cigarette and bidi) as the independent variables. All these variables except the 
last are considered continuous in each of the three models. Categories such as in Table 1 are arbitrary 
and can introduce bias. Therefore we decided against using any categories. The variables were entered 
in a sequential manner so that their utility in the presence of the previously entered variables can be 
evaluated. Analysis for partial contribution, which is the contribution in the presence of all the other 
variables, is also presented in Table 2 for all the models. Age, which is an independent risk factor, was 
entered first in each model. In Logistic-1, duration-of-smoking and cigarettes-per-day were entered 
together so that these can be compared with the conventional ‘cigarette-years’ that we study in 
Logistic-2. Next, we entered age-at-start and type-of-smoking. The other variable that we studied is 
‘years-since-stopped’ but this could not be entered in Logistic-1 because of redundancyyears-since-
stopped is a linear combination of age, duration-of-smoking and age-at-start. 
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Table 2.  Logistic regression results (all factors continuous except type of smoking) 
      Smokers + Non smokers (n=252) 
Model 
 
Sequential Partial 
Factors in the model 
 
   χ2 P-value    OR P-value 
Percent 
correctly 
classified 
   OR P-value 
None 346.23       
Logistic-1 
       
Age 29.39 0.0000 1.0520 0.0000 61.11 0.5969 0.0007 
 
Duration of smoking 
+ 
Cig./day 
 
 
67.81 
 
 
0.0000 
 
1.0704 
 
1.0689 
 
0.0001 
 
0.0005 
 
 
75.79 
 
 
2.0776 
 
1.0952 
 
0.0000 
 
0.0009 
 
Age at start 
+ 
Type of smoking 
     Never smoker (ref.) 
- Cig.− filter 
- Cig.− nonfilter 
- Bidi 
 
 
 
31.96 
 
 
0.0000 
 
1.8509 
 
 
1.0000 
0.4022 
0.6720 
0.9270 
 
0.0001 
 
 
 
0.4615 
0.6563 
0.9407 
 
 
81.75 
 
 
 
 
 
 
Same as for 
sequential 
Logistic-2        
Age 
 
29.39 0.0000 1.0520 0.0000 61.11 1.1342 0.0004 
 cig. years (S1) 67.66 0.0000 1.0078 0.0000 77.78 1.008 0.0003 
 
Age at start 
+ 
Years since stopped 
+ 
Type of smoking 
Never smoker (ref.) 
- Cig.− filter 
- Cig.− nonfilter 
- Bidi 
 
 
 
 
 
36.37 
 
 
 
 
0.0000 
 
0.9727 
 
0.5019 
 
    
1.0000 
1.1646 
2.1008 
2.9842 
 
0.4556 
 
0.0001 
 
0.1538 
   
0.8949 
0.3318 
0.2626 
 
 
 
 
82.54 
 
 
 
 
 
 
 
 
 
Same as for 
sequential 
Logistic-3        
Age 
 
29.39 0.0000 1.0520 0.0000 61.11 1.1189 0.0010 
Smoking index (S) 
 
102.80 0.0000 1.4132 0.0000 83.73 1.5535 0.0006 
 Cig. years (S1)  6.14 0.0132 0.9943 0.0134 83.73 0.9983 0.5737 
 
Age at start 
+ 
Years since stopped 
+ 
Type of smoking 
Never smoker (ref.) 
- Cig. − filter 
- Cig.− nonfilter 
- Bidi 
 
 
  
 
 
7.34 
 
 
 
 
 
0.1939 
 
1.0125 
 
0.7007 
 
    
1.0000 
0.9142 
0.9462 
1.6302 
 
0.7432 
 
0.0674 
 
0.5045 
   
0.9386 
0.9489 
0.6330 
 
 
 
 
83.73 
 
 
 
 
 
 
 
 
 
 
Same  as for 
sequential 
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Similar sequential entering of variables was done in Logistic-2 and Logistic-3 as well. In 
Logistic-2, duration-of-smoking and cigarettes-per-day were replaced by cigarette-years.  In this 
model, we could enter ‘years-since-stopped’ as an independent variable. In Logistic-3, we first 
entered our smoking index S after age, then cigarette-years, and then age-at-start, years-since-
stopped and type-of-smoking. Those entered together are shown bracketed on left in Table 2. The 
corresponding odds-ratios are also shown.  
 While interpreting these results, keep in mind that CAD is affected by a large number of 
other factors (obesity, exercise, stress, diet, etc.) that have not been included in our models. Our 
purpose is to examine the utility of smoking index S relative to the conventional smoking 
indicators, particularly cigarette-years. 
 In this series of subjects, the results of Logistic-1 show that all the smoking variables 
have statistically significant (P<0.05) association with CAD except categories of type-of-
smoking. Of a total chi-square of 346.23, the contribution of duration-of-smoking together with 
cigarettes-per-day is very high (67.81) relative to age (29.39) and age-at-start + type-of-smoking 
(31.96). Logistic model consisting of only age is able to correctly classify 61.11% subjects into 
CAD and non-CAD groups. This increased to 75.79% when duration-of-smoking and cigarettes-
per-day are included in the model. Inclusion of age-at-start and type-of-smoking increased it 
further to 81.75%. Less than one ORs for filter and non-filter cigarettes compared to never 
smoker is worrying but they are statistically not significant. 
 Now compare these with the results obtained when duration-of-smoking and cigarettes-
per-day are replaced by cigarette-years. These are given under Logistic-2 in Table 2. The chi-
square contribution of this variable is 67.66 compared to 67.81 of duration-of-smoking + 
cigarettes-per-day. The percent correctly classified are also nearly the same 77.78% compared 
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to 75.79% in the first model. Thus, cigarette-years has nearly the same efficiency in explaining 
CAD as jointly by duration-of-smoking and cigarette-per-day. Age-at-start, years-since-stopped 
and type-of-smoking together remains statistically significant (P<0.0001) even after cigarette-
years and age are in the model. Their contribution is not small. 
 Finally we enter our smoking index S after age in Logistic-3 model. Several important 
things occur when this is done. First, age-at-start, years-since-stopped and type-of-smoking loose 
statistical significance (P=0.1939) when S and cigarette-years are already in the model. This 
could indicate that these three aspects are adequately taken care of in the index S. Note that 
cigarette-years does not contain these variables.  Secondly the contribution of S to chi-square is 
102.80, which is much more than 67.66 of cigarette-years in Logistic-2. The per cent correctly 
classified also increases to 83.73 from 77.78 in Logistic-2 and 75.79 in Logistic-1 at this stage. 
This might mean that S could be better in explaining CAD odds than cigarette-years or duration-
of-smoking + cigarettes-per-day. What is worrying however is that cigarette-years is still 
statistically significant (P=0.0132) after S is in the model. This could mean that information in 
cigarette-years is not adequately accounted for in our index S. Nevertheless, note from Logistic-3 
results that the percentage correctly classified does not improve any more by other parameters 
once smoking index is the model. 
  As far as this series of subject goes, it is clear that the index S incorporates most 
of the information contained in different parameters of smoking though not all. Considering all 
the dimensions of smoking in multivariate set-up is still better although this is rarely done. We 
certainly do not claim S to be the final answer. It however seems to deserve attention and further 
trials for improvement. 
Application example 
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 As an application for inferential purposes on relation of CAD with smoking, note from 
Figure 4 how the percentage with CAD increases with the value of the smoking index.  Age is 
ignored in this figure. Discriminant function analysis shows that smoking index and age are able 
to correctly classify 80.1% smokers into CAD and non-CAD categories  (Figure 5). This figure is 
truncated at S=25, and  7  cases are excluded. Both indicate for this series of subjects that CAD is 
substantially associated with smoking index. If OR is interpreted as relative risk, which can be 
done for rare diseases, we find from logistic model that a unit increase in smoking index is 
associated with an increased risk of CAD by a factor of 1.41 among the clinic attendees when age 
is already in the model. Together, age and smoking index are able to contribute nearly 38% of the 
Chi-square in these subjects. 
A brief of this index is described by Indrayan[56]. 
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Figure 4 Relation of smoking index with CAD among preventive cardiology clinic 
attendees 
 
 Figure 5      Best discriminating line for CAD among smokers attending preventive 
    cardiology clinic 
 
 
Appendix 
 One general form of smoking index that can get rid of some assumptions is the following: 
   S = f(a) g(pS1) – h(y). 
The function f(a) delineates the role of age at start of smoking, which is (3-a/15) in our index. 
The function g(pS1) measures the burden due to dose of smoking. We assume it to be 
½ 5.0−∑ iii xnp  for the purpose of our index. The function h(y) is for relief in burden by the 
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duration elapsed since quitting by ex-smokers. We took it to be simply y itself. Various other 
forms of these functions can be suggested. In place of linearity assumed in Working Hypothesis-
II and Working Hypothesis-III, an exponential or parabolic decline can be considered. But that 
would make the index too complex for adoption. 
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Key Messages  
• Since smoking is predominant risk factor for many diseases and deaths, there is a need to 
measure it more comprehensively than done so far. 
• We propose an index of smoking that combines the effect of age at start, amount of smoking, 
duration of smoking, passive smoking, filter smoking, and duration elapsed since quitting, 
into a single metric. 
• The application of the index is demonstrated, and it is suggested that this be developed 
further. 
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